Oxford Biomedica (OXBDF) announces the appointment of Lucinda Crabtree Ph.D. as CFO and Board member. Simultaneously, the Company announces that Stuart Paynter will step down as CFO and from the Board after almost seven years of service. These changes will become effective on 2 September 2024 and Stuart will then transition away from Oxford Biomedica following a suitable handover period. Lucinda Crabtree was previously CFO at MorphoSys (MOR)
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OXBDF: